People · Operator
Named in public records as an officer, director or promoter · active 2017–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arrevus, Inc. | — | Biotechnology | Pre-Seed | $1.4M | $8.3M | 2017 |
Barry W. Garfinkle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Barry W. Garfinkle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ROBERT N SCHOTZINGER | 1 | 1 |
| CARL N KRAUS | 1 | 1 |
| ROBERT V HOUSE | 1 | 1 |
| JOSEPH W ST. GEME | 1 | 1 |
| JOE N MCMAHON | 1 | 1 |
| BARRY N GARFINKLE | 1 | 1 |
| DORIS N SNOW | 1 | 1 |
| Doris M. Snow | 1 | 1 |
| Joe W. McMahon | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.